1.
Modernizing the Nonhomologous End-Joining Repertoire: Alternative and Classical NHEJ Share the Stage
by Deriano, Ludovic
Annual review of genetics, 2013, Vol.47 (1), p.433-455
2.
Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA
by Richardson, Christopher D
Nature biotechnology, 2016, Vol.34 (3), p.339-344
3.
Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining
by Maruyama, Takeshi
Nature biotechnology, 2015, Vol.33 (5), p.538-542
4.
Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells
by Chu, Van Trung
Nature biotechnology, 2015, Vol.33 (5), p.543-548
5.
ELL2 regulates DNA non-homologous end joining (NHEJ) repair in prostate cancer cells
by Zang, Yachen
Cancer letters, 2018, Vol.415, p.198-207
6.
A comparative analysis of insertional effects in genetically engineered plants: considerations for pre-market assessments
by Schnell, Jaimie
Transgenic research, 2014, Vol.24 (1), p.1-17
7.
Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells
by Meng, Xiangning
Journal of medical genetics, 2015, Vol.52 (2), p.135-144
8.
Efficient gene targeting in mouse zygotes mediated by CRISPR/Cas9-protein
by Jung, Chris J
Transgenic research, 2016, Vol.26 (2), p.263-277
9.
Association of XRCC5 VNTR polymorphism with the development of chronic myeloid leukemia
by Gorre, Manjula
Tumor biology, 2013, Vol.35 (2), p.923-927
10.
Double-Strand Break End Resection and Repair Pathway Choice
by Symington, Lorraine S
Annual review of genetics, 2011, Vol.45 (1), p.247-271
11.
Genome Engineering with Targetable Nucleases
by Carroll, Dana
Annual review of biochemistry, 2014, Vol.83 (1), p.409-439
12.
Quantifying on- and off-target genome editing
by Hendel, Ayal
Trends in biotechnology (Regular ed.), 2014, Vol.33 (2), p.132-140
13.
A Life Investigating Pathways That Repair Broken Chromosomes
by Haber, James E
Annual review of genetics, 2016, Vol.50 (1), p.1-28
14.
BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy
by Oing, Christoph
Cancer letters, 2018, Vol.423, p.60-70
15.
Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency
by Canny, Marella D
Nature biotechnology, 2018, Vol.36 (1), p.95-102
16.
XRCC4 deficiency in human subjects causes a marked neurological phenotype but no overt immunodeficiency
by Guo, Chaowan, PhD
Journal of allergy and clinical immunology, 2015, Vol.136 (4), p.1007-1017
17.
DNA double-strand break repair: All's well that ends well
by Wyman, C.L
Annual review of genetics, 2006, Vol.40 (1), p.363-383
18.
Plant genome engineering with sequence-specific nucleases
by Voytas, Daniel F
Annual review of plant biology, 2013, Vol.64 (1), p.327-350
19.
G9a inhibition potentiates anti-tumor activity of DNA double-strand break inducing agents by impairing DNA repair independent of p53 status
by Agarwal, Pallavi
Cancer letters, 2016, Vol.380 (2), p.467-475
20.
Regulation of DNA double-strand break repair pathway choice
by Shrivastav, Meena
Cell research, 2008, Vol.18 (1), p.134-147
